Trial Profile
GnRH analogs Ovarian Protection Against Gonadotoxic Agents [ANALOGOS DE GNRH Y PROTECCION OVARICA FRENTE A AGENTES GONADOTOXICOS]
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2013
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Ovarian disorders
- Focus Therapeutic Use
- 22 Oct 2013 Status changed from recruiting to discontinued.
- 31 May 2012 New trial record